JATENZO 158 MG CAPSULE
FDA nonproprietary name: testosterone undecanoate
For 30 capsules
Pharmacies pay
$269.16 filed
30 × $8.97187 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$396.03 filed
30 × $13.20103 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.5× estimated
Medicare paid 1.5× what pharmacies pay.
Part D averages every strength and form sold under “Jatenzo” / “Testosterone Undecanoate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$314.53 estimated
$269.16 + $40.37 (15%) + $5.00 fee per fill = $314.53
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
JATENZO 158 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as testosterone undecanoate, under the trade name “Jatenzo”.
FDA gives its dosage form as capsule, liquid filled and its route as oral.
The labeler, the company named on the label, is TOLMAR Inc.
FDA’s Established Pharmacologic Class for it is Androgen.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 69087-0158-12.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $269.16 for 30 capsules (30 × $8.97187 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 capsules · NADAC explanation codes
The NDC
- 69087-0158-12 · TOLMAR Inc. · $8.97187 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
3 other products in the NADAC file share the FDA nonproprietary name testosterone undecanoate with JATENZO 158 MG CAPSULE.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| JATENZO 158 MG CAPSULE this page | $8.97187 per EA filed | $13.20103 per EA filed |
| JATENZO 198 MG CAPSULE | $8.9534 per EA filed | $13.20103 per EA filed |
| JATENZO 237 MG CAPSULE | $17.93094 per EA filed | $13.20103 per EA filed |
| TLANDO 112.5 MG CAPSULE | $7.16533 per EA filed | $6.00661 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $8.97187 per EA filed.
Of the 6 other products in FDA’s Androgen class priced per EA, 1 has a higher middle NADAC price and 5 a lower one. The one in the middle is DANAZOL 200 MG CAPSULE, at $2.65221 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $396.03 for 30 capsules, at an average of $13.20103 per EA in 2024 (2024-01-01 to 2024-12-31) for “Jatenzo” and “Testosterone Undecanoate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 7,521 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for JATENZO 158 MG CAPSULE labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Jatenzo / Testosterone Undecanoate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Related pages
Its pharmacologic class
Related in the same class
- TESTOSTERONE CYP 1,000 MG/10 ML
- XYOSTED 100 MG/0.5 ML AUTO-INJ
- DANAZOL 100 MG CAPSULE
- TESTIM 1% (50 MG) GEL